Stock Analysis

February 2025's Top Stock Picks Estimated To Be Trading Below Fair Value

Published

As global markets navigate a landscape marked by interest rate adjustments and competitive pressures in the technology sector, investors are keenly observing the implications for stock valuations. Amidst this volatility, identifying stocks trading below their fair value can be a prudent strategy for those looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Alltop Technology (TPEX:3526)NT$263.50NT$528.6750.2%
Brookline Bancorp (NasdaqGS:BRKL)US$12.06US$24.0149.8%
Sichuan Injet Electric (SZSE:300820)CN¥50.58CN¥101.0149.9%
Nordic Waterproofing Holding (OM:NWG)SEK170.60SEK340.7049.9%
Elekta (OM:EKTA B)SEK64.60SEK128.3649.7%
Kinaxis (TSX:KXS)CA$171.05CA$340.4149.8%
GemPharmatech (SHSE:688046)CN¥13.06CN¥25.9449.7%
AeroEdge (TSE:7409)¥1771.00¥3417.3748.2%
QuinStreet (NasdaqGS:QNST)US$23.71US$47.3549.9%
Equifax (NYSE:EFX)US$267.52US$531.2749.6%

Click here to see the full list of 913 stocks from our Undervalued Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

Ryman Healthcare (NZSE:RYM)

Overview: Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for elderly people in New Zealand and Australia, with a market cap of NZ$3 billion.

Operations: The company's revenue segment primarily consists of the provision of integrated retirement villages for older people, generating NZ$720.35 million.

Estimated Discount To Fair Value: 34.7%

Ryman Healthcare is trading at NZ$4.38, significantly below its estimated fair value of NZ$6.7, indicating undervaluation based on discounted cash flow analysis. Despite a high debt level and a forecasted low return on equity of 5.9% in three years, revenue is expected to grow at 9.2% annually, outpacing the broader New Zealand market growth rate of 4.6%. Analysts forecast profitability within three years with substantial earnings growth potential.

NZSE:RYM Discounted Cash Flow as at Feb 2025

CGN Mining (SEHK:1164)

Overview: CGN Mining Company Limited focuses on the development and trading of natural uranium resources for nuclear power plants, with a market capitalization of HK$12.31 billion.

Operations: The company generates revenue primarily from its natural uranium trading segment, which amounts to HK$8.50 billion.

Estimated Discount To Fair Value: 47%

CGN Mining is trading at HK$1.62, well below its estimated fair value of HK$3.05, highlighting potential undervaluation based on cash flows. Despite low profit margins and debt not being well covered by operating cash flow, the company has shown strong earnings growth of 26.8% last year and is forecast to grow earnings by 39.2% annually, significantly outpacing the Hong Kong market's growth rate of 11.3%.

SEHK:1164 Discounted Cash Flow as at Feb 2025

Super Hi International Holding (SEHK:9658)

Overview: Super Hi International Holding Ltd. is an investment holding company that operates Haidilao branded Chinese cuisine restaurants across Asia, North America, and internationally, with a market cap of HK$12.41 billion.

Operations: The company's revenue is primarily generated from its Haidilao branded Chinese cuisine restaurants, amounting to $759.89 million.

Estimated Discount To Fair Value: 11%

Super Hi International Holding, trading at HK$19.08, is undervalued relative to its estimated fair value of HK$21.43 based on cash flows. The company reported significant earnings growth with a net income of US$37.72 million for Q3 2024, reversing a loss from the previous year. Earnings are forecast to grow significantly over the next three years, outpacing both revenue growth and the broader Hong Kong market's earnings growth rate.

SEHK:9658 Discounted Cash Flow as at Feb 2025

Taking Advantage

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com